Acorah Software Products - Accounts Production 19.2.350 false true 31 March 2025 1 April 2024 false true No description of principal activity 1 April 2025 31 March 2026 31 March 2026 10686734 Dr Qamar Ghafoor Mrs Natalie Ghafoor iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10686734 2025-03-31 10686734 2026-03-31 10686734 2025-04-01 2026-03-31 10686734 frs-core:CurrentFinancialInstruments 2026-03-31 10686734 frs-bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 10686734 frs-bus:FilletedAccounts 2025-04-01 2026-03-31 10686734 frs-bus:Micro-entities 2025-04-01 2026-03-31 10686734 frs-bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 10686734 frs-bus:Director1 2025-04-01 2026-03-31 10686734 frs-bus:Director2 2025-04-01 2026-03-31 10686734 2024-03-31 10686734 2025-03-31 10686734 2024-04-01 2025-03-31 10686734 frs-core:CurrentFinancialInstruments 2025-03-31
Registered number: 10686734
QINS ONCOLOGY LIMITED
Unaudited Financial Statements
For The Year Ended 31 March 2026
Medical Finance Limited
Balance Sheet
Registered number: 10686734
2026 2025
£ £
Fixed assets 69,822 73,178
Current assets 186,394 154,738
Creditors: Amounts Falling Due Within One Year (13,188 ) (7,112 )
NET CURRENT ASSETS 173,206 147,626
TOTAL ASSETS LESS CURRENT LIABILITIES 243,028 220,804
Accruals and deferred income (35,000 ) (35,000 )
NET ASSETS 208,028 185,804
CAPITAL AND RESERVES 208,028 185,804

Notes

1. General Information
QINS ONCOLOGY LIMITED is a private company, limited by shares, incorporated in England & Wales, registered number 10686734 . The registered office is 118 Middleton Hall Road, Birmingham, West Midlands, England, B30 1DH.
2. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2025: NIL)
- -
For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Qamar Ghafoor
Director
22/06/2026